Long-Term Survival Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results From BENEFIT-EXT

被引：0
|
作者：
Florman, S. [1 ]
Bray, R. [2 ]
Gebel, H. [2 ]
Kuypers, D. [3 ]
Larsen, C. [2 ]
Medina Pestana, J. [4 ]
Rial, M. [5 ]
Rostaing, L. [6 ]
Wekerle, T. [7 ]
Grannas, G. [8 ]
Meier-Kriesche, U. [9 ]
Polinsky, M. [9 ]
Townsend, R. [9 ]
Munier, S. [9 ]
Grinyo, J. [10 ]
Durrbach, A. [11 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Hosp Rim, Sao Paulo, Brazil
[5] Inst Nefrol, Buenos Aires, DF, Argentina
[6] Univ Hosp, Toulouse, France
[7] Med Univ Vienna, Vienna, Austria
[8] Hannover Med Sch, D-30623 Hannover, Germany
[9] Bristol Myers Squibb, Lawrenceville, NJ USA
[10] Univ Hosp Bellvitge, Barcelona, Spain
[11] Univ Hop Bicetre, Villejuif, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P-45
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS. CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
    Durrbach, Antoine
    Medina, Pestana Jose
    Florman, Sander
    Del Carmen, Rial Maria
    Rostaing, Lionel
    Kuypers, Dirk
    Wekerle, Thomas
    Polinsky, Martin
    Meier-Kriesche, Herwig-Ulf
    Grinyo, Josep
    TRANSPLANT INTERNATIONAL, 2015, 28 : 81 - 81
  • [2] LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS. CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
    Durrbach, A.
    Bray, R.
    Gebel, H.
    Florman, S.
    Kuypers, D.
    Larsen, C. P.
    Pestana, J. M.
    del Carmen Rial, M.
    Rostaing, L.
    Wekerle, T.
    Meier-Kriesche, U.
    Polinsky, M.
    Townsend, R.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 10 - 10
  • [3] Long-term survival outcomes in belatacept-treated vs cyclosporine-treated patients: final results from BENEFIT-EXT
    Durrbach, Antoine
    Bray, Robert
    Gebel, Howard
    Florman, Sander
    Kuypers, Dirk
    Larsen, Christian P.
    Pestana, Jose Medina
    Del Carmen Rial, Maria
    Rostaing, Lionel
    Wekerle, Thomas
    Meier-Kriesche, Ulf
    Polinsky, Martin
    Townsend, Robert
    Grinyo, Josep
    SWISS MEDICAL WEEKLY, 2015, 145 : 41S - 41S
  • [4] LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
    Durrbach, A.
    Bray, R.
    Gebel, H.
    Florman, S.
    Kuypers, D.
    Larsen, C. P.
    Pestana, J. Medina
    Del Carmen Rial, M.
    Rostaing, L.
    Wekerle, T.
    Meier-Kriesche, U.
    Polinsky, M.
    Townsend, R.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 8 - 8
  • [5] LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VERSUS CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
    Durrbach, A.
    Florman, S.
    Kuypers, D.
    Medina Pestana, J.
    del Carmen Rial, M.
    Rostaing, L.
    Wekerle, T.
    Meier-Kriesche, U.
    Polinsky, M.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 51 - 51
  • [6] Belatacept-Treated Patients Had Superior Graft Survival vs. Cyclosporine-Treated Patients: Final Results From BENEFIT F
    Vincenti, F.
    Grinyo, J.
    Bray, R.
    Rostaing, L.
    Bresnahan, B.
    Rice, K.
    Steinberg, S.
    Gebel, H.
    Polinsky, M.
    Meier-Kriesche, U.
    Munier, S.
    Townsend, R.
    Larsen, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 44 - 44
  • [7] BELATACEPT-TREATED PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
    Vincenti, F.
    Bray, R.
    Gebel, H.
    Grinyo, J.
    Moal, M. C.
    Rice, K.
    Rostaing, L.
    Steinberg, S.
    Meier-Kriesche, U.
    Polinsky, M.
    Townsend, R.
    Larsen, C. P.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 8 - 8
  • [8] Belatacept-treated patients had superior graft survival compared with cyclosporine-treated patients: final results from BENEFIT
    Vincenti, Flavio
    Bray, Robert
    Gebel, Howard
    Grinyo, Josep
    Moal, Marie-Christine
    Rice, Kim
    Rostaing, Lionel
    Steinberg, Steven
    Meier-Kriesche, Ulf
    Polinsky, Martin
    Townsend, Robert
    Larsen, Christian P.
    SWISS MEDICAL WEEKLY, 2015, 145 : 10S - 11S
  • [9] BELATACEPT-TREATED PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
    Vincenti, F.
    Grinyo, J.
    Moal, M. -C.
    Rice, K.
    Rostaing, L.
    Steinberg, S.
    Meier-Kriesche, U.
    Polinsky, M.
    Larsen, C. P.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 51 - 51
  • [10] Reduced Conversion from IgM Anti-HLA-DSA to IgG Anti-HLA-DSA in Belatacept-Treated vs. Cyclosporine-Treated Patients in BENEFIT and BENEFIT-EXT Trials
    Everly, M.
    Townsend, R.
    Gebel, H.
    Bray, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 266 - 267
12345